Active, not recruiting

4

1127

RoW

Yangzheng Compound Mixture, Z10970042（NMPA Approval Number）, Conventional Treatment

ShuGuang Hospital, LinkDoc Technology (Beijing) Co. Ltd., Shaanxi Buchang Pharmaceutical Co., Ltd

Carcinoma, Sleep Disorder

09/23

06/24

Completed

4

157

RoW

rhTPO, Recombinant human thrombopoietin, TPIAO, Eltrombopag, Eltrombopag olamine

Institute of Hematology & Blood Diseases Hospital, China, The Second Hospital of Hebei Medical University, Xijing Hospital, The Affiliated Hospital of Inner Mongolia Medical University, The Second Affiliated Hospital of Kunming Medical University, Second Affiliated Hospital of Guangzhou Medical University, Shaanxi Provincial People's Hospital, Henan Cancer Hospital, North China University of Science and Technology Affiliated Hospital, The Second Affiliated Hospital of Dalian Medical University, Second Hospital of Shanxi Medical University, The Second Affiliated Hospital of Harbin Medical University, Shenyang Sunshine Pharmaceutical Co., LTD., First Affiliated Hospital of Xinjiang Medical University, People's Hospital of Xinjiang Uygur Autonomous Region, Kashgar 1st People's Hospital, Xi'an Central Hospital, Beijing Public Health Foundation, Yuyao People's Hospital of Zhejiang Province

Previously Treated Primary Immune Thrombocytopenia

02/24

07/24

Completed

3

765

RoW

TPN171H 2.5mg group, Simmerafil, TPN171H 5mg group, TPN171H 10mg group, Placebo group

Vigonvita Life Sciences

Erectile Dysfunction

02/23

02/23

Not yet recruiting

3

528

RoW

Anlotinib hydrochloride capsule, AK105 injection, Paclitaxel injection, Docetaxel injection

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Advanced Gastric and Gastro-oesophageal Junction Adenocarcinoma

10/23

12/23

Recruiting

3

918

Europe, Canada, Japan, RoW

Zanidatamab, ZW25, JZP598, Tislelizumab, Trastuzumab, Herceptin®, Capecitabine, Oxaliplatin, Cisplatin, 5-Fluorouracil

Jazz Pharmaceuticals, BeiGene, Ltd.

Gastric Neoplasms, Gastroesophageal Adenocarcinoma, Esophageal Adenocarcinoma

05/25

05/26

Completed

3

359

RoW

FF/VI, FF/UMEC/VI, ELLIPTA

GlaxoSmithKline

Asthma

08/24

08/24

Recruiting

3

195

RoW

Orelabrutinib, Placebo

Beijing InnoCare Pharma Tech Co., Ltd.

Chronic Primary Immune Thrombocytopenia (ITP)

12/25

04/26

Recruiting

2

88

RoW

RC88, RC88 for Injection

RemeGen Co., Ltd.

Primary Peritoneal Cancer, Fallopian Tube Cancer, Epithelial Ovarian Cancer

06/26

12/26

Recruiting

2

108

RoW

HLX10

Shanghai Henlius Biotech

MSI-H Solid Malignant Tumor

05/24

06/26

Terminated

1/2

15

RoW

ATG-016

Shanghai Antengene Corporation Limited

Myelodysplastic Syndrome

09/23

09/23

Recruiting

1/2

39

RoW

400mg of TQB3909 tablets, 600mg of TQB3909 tablets

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

Mantle Cell Lymphoma

12/24

12/24

Recruiting

1

60

RoW

Pelcitoclax, APG-1252

Ascentage Pharma Group Inc.

Neuroendocrine Tumors

06/24

06/25

Recruiting

1

20

RoW

RD06-04 CART Cell Injection

Nanjing Bioheng Biotech Co., Ltd.

SLE (Systemic Lupus), Systemic Sclerosis, ANCA Associated Vasculitis, Idiopathic Inflammatory Myopathies, Sjogren's Syndrome, Autoimmune Diseases

07/26

07/27

Not yet recruiting

1

69

RoW

Extracellular vesicles derived from human-induced neural stem cells for intrathecal injection, NouvSoma001, A placebo of extracellular vesicles derived from human-induced neural stem cells for intrathecal injection

Tongji Hospital, iRegene Therapeutics Co., Ltd.

Neuromyelitis Optica Spectrum Disorders

11/25

11/27

Recruiting

N/A

196

RoW

CRT, concurrent chemoradiotherapy, surgery, esophagectomy

The First Affiliated Hospital of Henan University of Science and Technology, Jiangsu HengRui Medicine Co., Ltd., Anyang Tumor Hospital, 150th Hospital of PLA

Esophagus Cancer

Completed

N/A

1507

RoW

Prospective observational cohort study

GlaxoSmithKline

Pulmonary Disease, Chronic Obstructive

11/22

02/23

Completed

N/A

188

RoW

DKutting LL balloon, Chocolate balloon

DK Medical Technology (Suzhou) Co., Ltd.

Femoral Artery Stenosis, Popliteal Artery Stenosis

01/24

02/24

Recruiting

N/A

12

RoW

Deep Brain stimulation

West China Hospital, Beijing Pins Medical Co., Ltd

Major Depressive Disorder, Treatment Resistant Depression

07/26

12/26

Active, not recruiting

N/A

10560

RoW

ctDNA methylation analysis by NGS

AnchorDx Medical Co., Ltd., Xiangya Hospital of Central South University, West China Hospital, Shanghai Zhongshan Hospital, Shanghai Pulmonary Hospital affiliated to Tongji University, First Hospital of China Medical University, Guizhou Provincial People's Hospital, Shanghai Chest Hospital, First Affiliated Hospital, Sun Yat-Sen University, First Affiliated Hospital Xi'an Jiaotong University, Qilu Hospital of Shandong University, Inner Mongolia People's Hospital, The First Affiliated Hospital with Nanjing Medical University, The First Affiliated Hospital of Zhengzhou University, Second Hospital of Jilin University, LanZhou University, Peking University Third Hospital, The First People's Hospital of Yunnan, Shantou Affiliated Hospital of Sun Yat-Sen University, Ruijin Hospital, The Shanghai Jiao Tong University Medical School, Tongji Hospital, The First Affiliated Hospital of Guangzhou Medical University, Xijing Hospital, Air Force Medical University of PLA, Shenzhen People's Hospital, Henan Provincial People's Hospital, Beijing Chao Yang Hospital, Xiamen Second Hospital, The First Affiliated Hospital of Nanchang University

Pulmonary Nodules

09/24

06/25

Recruiting

N/A

50000

RoW

comprehensive management algorithm for preventing mother-to-child transmission of HBV

Nanfang Hospital of Southern Medical University, Chinese Foundation for Hepatitis Prevention and Control, Tigermed Consulting Co., Ltd

Hepatitis B, Chronic, Mother to Child Transmission

06/25

12/25

Active, not recruiting

4

8250

RoW

Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy

Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd.

Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases

04/25

04/25

Recruiting

3

552

RoW

ICP-332 Tablets, ICP-332 Placebo Tablets

Beijing InnoCare Pharma Tech Co., Ltd.

Atopic Dermatitis

11/26

12/26

Recruiting

2

120

RoW

TQH3906 capsules, Placebo of TQH3906 capsules

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

Plaque Psoriasis

01/25

09/25

Active, not recruiting

N/A

7656

RoW

JT001, DeuremidevirHydrobromideTablets

Shanghai Vinnerna Biosciences Co., Ltd.

COVID-19

11/24

12/24

Recruiting

2

120

RoW

TQH3906 capsules, Placebo of TQH3906 capsules

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

Plaque Psoriasis

01/25

09/25

Recruiting

3

495

RoW

Shugan Jieyu Capsules, Shugan Jieyu Capsules Placebo

Sichuan Jishengtang Pharmaceutical Co., Ltd.

Generalized Anxiety Disorder

02/25

06/25

Recruiting

2

260

RoW

Placebo group, JS1-1-01 placebo pills; Duloxetine hydrochloride placebo capsules, JS1-1-01 low-dose group, JS1-1-01 pills; JS1-1-01 placebo pills; Duloxetine hydrochloride placebo capsules, JS1-1-01 pills; JS1-1-01 placebo pills, JS1-1-01 high-dose group, JS1-1-01 pills; Duloxetine hydrochloride placebo capsules, Active drug group, JS1-1-01 placebo pills; Duloxetine hydrochloride enteric coated capsule

Tasly Pharmaceutical Group Co., Ltd

Depression

04/25

04/25

Completed

1/2

50

RoW

BDB-001 Injection, Placebo

Staidson (Beijing) Biopharmaceuticals Co., Ltd

Hidradenitis Suppurativa

07/23

07/23

Recruiting

1/2

1300

Canada, US, RoW

SKB264

Klus Pharma Inc.

Epithelial Ovarian Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Urothelial Carcinoma, Non-Small Cell Lung Cancer, Small-Cell Lung Cancer, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, Breast Cancer

08/25

07/26

Recruiting

1

88

RoW

2mg KH607 tablets, 5mg KH607 tablets, 10mg KH607 tablets, 20mg KH607 tablets, 30mg KH607 tablets, 40mg KH607 tablets, 50mg KH607 tablets, 60mg KH607 tablets

Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Healthy

10/24

10/24

Recruiting

1

32

RoW

VV119 Placebo （in healthy adult subjects）, VV119 （in healthy adult subjects）, VV119(in adult patients with schizophrenia), VV119 Placebo （in adult patients with schizophrenia）

Vigonvita Life Sciences

Schizophrenia

07/25

07/25

Recruiting

2

240

Europe, Canada, US, RoW

SKB264, Pembrolizumab, Keytruda

Klus Pharma Inc., Myriad Genetics, Inc., Discovery Life Sciences, LLC, Ventana Medical Systems, Inc, Frontage Laboratories, Inc.

Solid Tumor

11/26

12/27

Completed

1/2

31

RoW

TNM001, Placebo

Zhuhai Trinomab Pharmaceutical Co., Ltd.

Respiratory Syncytial Virus Infections

06/23

06/23

Recruiting

1

48

RoW

TWP-201, placebo

Shandong TheraWisdom Biopharma Co., Ltd.

Infertility

10/22

12/22

Not yet recruiting

1

120

RoW

30μg dose of LYB002V14, 60μg dose of LYB002V14, placebo

Guangzhou Patronus Biotech Co., Ltd., Yantai Patronus Biotech Co., Ltd.

SARS-CoV-2, COVID-19 Vaccine

12/24

12/24

Recruiting

1

111

RoW

SPH7854, Placebo

Shanghai Pharmaceuticals Holding Co., Ltd

Inflammatory Bowel Disease

12/25

12/25

Recruiting

4

24000

RoW

Amlodipine besylate, Amlodipine, Amlodipine besylate And Folic Acid, Amlodipine Folic Acid, Anye, 5-methyltetrahydrofolate (5-MTHF), 5-MTHF, Amlodipine placebo, Amlodipine (dummy), Amlodipine folic acid placebo, Amlodipine folic acid (dummy), 5-MTHF Placebos, 5-MTHF (dummy)

Shenzhen Ausa Pharmed Co.,Ltd, Peking University First Hospital, Second Affiliated Hospital of Nanchang University, The First People's Hospital of Lianyungang, The Affiliated Hospital Of Guizhou Medical University, Lianyungang Oriental Hospital, Tengzhou Central People's Hospital, First Affiliated Hospital Bengbu Medical College, H & J CRO International, Inc., Shenzhen Prospective Medical Technology Co., LTD

Hypertension, MTHFR 677 TT Genotype

06/29

06/29

Terminated

3

89

RoW

Icaritin, Sorafenib Tosylate Tablets

Beijing Shenogen Biomedical Co., Ltd, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Eastern Theater General Hospital,QinHuai District Medical Area, Peking University Cancer Hospital & Institute, Chinese PLA General Hospital, Beijing Hospital, General Hospital of Chinese Armed Police Forces, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Jinan Central Hospital, Linyi Cancer Hospital, The First Affiliated Hospital of Anhui Medical University, Anhui Provincial Hospital, The First Affiliated Hospital with Nanjing Medical University, The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China, Nanfang Hospital of Southern Medical University, First People's Hospital of Foshan, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Tianjin Medical University Cancer Institute and Hospital, The Fourth Hospital of Hebei Medical University, Hunan Cancer Hospital, The First Hospital of Jilin University, 307 Hospital of PLA, Fudan University, Henan Cancer Hospital, Jilin Provincial Tumor Hospital, First Affiliated Hospital of Harbin Medical University, First Affiliated Hospital Bengbu Medical College, The First Affiliated Hospital of Soochow University, Tongji Hospital, Beijing YouAn Hospital

Hepatocellular Carcinoma (HCC)

02/22

02/22

Not yet recruiting

3

332

RoW

TQB2450, Anlotinib, Paclitaxel for Injection (albumin bound)

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Triple Negative Breast Cancer

07/22

07/22

Recruiting

3

366

RoW

RC48-ADC, RC48, Paclitaxel Injection, Taxol, Docetaxel Injection, Taxotere, Vinorelbine Tartrate Injection, Navelbine, Capecitabine Tablets, Xeloda

RemeGen Co., Ltd.

Breast Cancer

06/24

12/24

Recruiting

3

256

US, RoW

Afuresertib, Fulvestrant, Afuresertib/placebo

Laekna Limited

Breast Cancer

10/26

12/26

Completed

3

275

RoW

GB491+ Fulvestrant, test drug + Fulvestrant, Placebo+Fulvestrant, placebo control + Fulvestrant

Genor Biopharma Co., Ltd.

Locally Advanced or Metastatic Breast Cancer

12/22

03/24

Completed

3

248

RoW

Hydronidone capsules, F351, The placebo capsules, N

Beijing Continent Pharmaceutical Co, Ltd.

Liver Fibrosis

10/24

10/24

Active, not recruiting

3

408

RoW

KN046, placebo

Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Advanced Pancreatic Ductal Adenocarcinoma

04/24

08/24

Active, not recruiting

3

654

Europe, Canada, Japan, US, RoW

Tucatinib, TUKYSA, ONT-380, ARRY-380, Trastuzumab, Herceptin, Herceptin Hylecta, Pertuzumab, Perjeta, Combination product: Trastuzumab + Pertuzumab, Phesgo, Placebo

Seagen Inc., Merck Sharp & Dohme LLC

HER2 Positive Breast Cancer

05/25

10/27

Recruiting

3

350

RoW

GB491 combined with Letrozole, Placebo combined with Letrozole

Genor Biopharma Co., Ltd.

Breast Cancer

01/26

01/27

Active, not recruiting

2/3

549

Europe, RoW

Oral paclitaxel, Liporaxel®, Paclitaxel injection, Taxol®

Daehwa Pharmaceutical Co., Ltd., Daehwa pharmaceutical Co., Ltd.

Recurrent or Metastatic Breast Cancer

02/24

12/25

Recruiting

2/3

104

RoW

B007, Placebo

Shanghai Jiaolian Drug Research and Development Co., Ltd, Shanghai Pharmaceuticals Holding Co., Ltd

Generalized Myasthenia Gravis

06/26

06/26

Active, not recruiting

2

57

RoW

RC48-ADC, Recombinant Humanized anti-HER2 Monoclonal Antibody-MMAE Conjugate For Injection

RemeGen Co., Ltd.

Biliary Tract Cancer

11/23

06/24

Active, not recruiting

2

103

RoW

Encorafenib, Braftovi®, PF-07263896, W0090, LGX818, ONO-7702, Cetuximab, Erbitux®, C225, FOLFIRI, Folinic acid + Fluorouracil + Irinotecan

Pierre Fabre Medicament, Merck KGaA, Darmstadt, Germany

BRAF V600E, Metastatic Colorectal Cancer

12/23

01/25